Genome Editing & Gene Modulation International Congress takes place in Oxford
Published: Monday, April 11th, 2016
Tags: Corporate News, CRISPR
AATI scientist presents research at international conference on CRISPR in Oxford, UK.
While in attendance at The Genome Editing & and Gene Modulation International Congress, Dr. Kyle Luttgeharm presented on the Development of a high throughput screening protocol for rapid identification of mutated alleles. The talk highlighted work done at AATI developing a method to simply and efficiently identify CRISPR/Cas9 induced mutations within a target sequence. With most work on CRISPR/Cas9 focused on the efficient editing of genes and genomes, the work at AATI stood out as methods of mutation detection have lagged behind the ability to precisely engineer genes and genomes. Dr. Luttgeharm was enthused by the positive response stating, "Attendees were very interested in how endonuclease assays could be used to determine the zygosity of individual cell lines or organisms, as well as ways AATI's Fragment Analyzer can be used to detect and quantify mutated alleles".
Additionally, Dr. Luttgeharm, Application Scientist at AATI, was able to network with fellow researchers and stay current on advancements in genetic and genomic modification. Topics presented and discussed included minimizing off-target effects, current Cas9 guide RNA delivery techniques, and promoting homology directed repair events.